title: Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
authors.forename: P
authors.initials: P
authors.lastname: Thangadurai
authors.forename: K S
authors.initials: KS
authors.lastname: Jyothi
authors.forename: Rajesh
authors.initials: R
authors.lastname: Gopalakrishnan
authors.forename: Anju
authors.initials: A
authors.lastname: Kuruvilla
authors.forename: K S
authors.initials: KS
authors.lastname: Jacob
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D016903:Drug Monitoring; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000097:blood / Q000139:chemically induced*; D009504:Neutrophils; D000077152:Olanzapine; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D003024:Clozapine; D000077152:Olanzapine